Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Bastiaannet

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 3, 2016
The predictive power of serum S-100B for non-sentinel node positivity in melanoma patientsS Damude, H J Hoekstra, E Bastiaannet, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 5, 2008
Therapeutic groin dissection for melanoma: risk factors for short term morbidityH P A M Poos, S Kruijff, E Bastiaannet, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 2011
The value of pre operative S-100B and SUV in clinically stage III melanoma patients undergoing therapeutic lymph node dissectionS Kruijff, E Bastiaannet, M J Speijers, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 5, 2017
Treatment recommendations for older women with breast cancer: A survey among surgical, radiation and medical oncologistsV C Hamelinck, A M Stiggelbout, C J H van de Velde, et al.
Annals of Surgical Oncology|March 21, 2013
S-100B: a stronger prognostic biomarker than LDH in stage IIIB-C melanomaK P Wevers, S Kruijff, M J Speijers, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 9, 2016
A systematic review and meta-analyses of sentinel lymph node identification in breast cancer and melanoma, a plea for tracer mappingM G Niebling, R G Pleijhuis, E Bastiaannet, et al.
Annals of Surgical Oncology|July 29, 2009
S-100B concentrations predict disease-free survival in stage III melanoma patientsS Kruijff, E Bastiaannet, A C Muller Kobold, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 10, 2012
Assessment of a new scoring system for predicting non-sentinel node positivity in sentinel node-positive melanoma patientsK P Wevers, R Murali, E Bastiaannet, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 18, 2012
Prognostic value of the standardized uptake value for (18)F-fluorodeoxyglucose in patients with stage IIIB melanomaE Bastiaannet, O S Hoekstra, J R de Jong, et al.
The British Journal of Surgery|December 3, 2005
Impact of [18F]fluorodeoxyglucose positron emission tomography on surgical management of melanoma patientsE Bastiaannet, W J G Oyen, S Meijer, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 3, 2016
The predictive power of serum S-100B for non-sentinel node positivity in melanoma patientsS Damude, H J Hoekstra, E Bastiaannet, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 5, 2008
Therapeutic groin dissection for melanoma: risk factors for short term morbidityH P A M Poos, S Kruijff, E Bastiaannet, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 2011
The value of pre operative S-100B and SUV in clinically stage III melanoma patients undergoing therapeutic lymph node dissectionS Kruijff, E Bastiaannet, M J Speijers, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 5, 2017
Treatment recommendations for older women with breast cancer: A survey among surgical, radiation and medical oncologistsV C Hamelinck, A M Stiggelbout, C J H van de Velde, et al.
Annals of Surgical Oncology|March 21, 2013
S-100B: a stronger prognostic biomarker than LDH in stage IIIB-C melanomaK P Wevers, S Kruijff, M J Speijers, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 9, 2016
A systematic review and meta-analyses of sentinel lymph node identification in breast cancer and melanoma, a plea for tracer mappingM G Niebling, R G Pleijhuis, E Bastiaannet, et al.
Annals of Surgical Oncology|July 29, 2009
S-100B concentrations predict disease-free survival in stage III melanoma patientsS Kruijff, E Bastiaannet, A C Muller Kobold, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 10, 2012
Assessment of a new scoring system for predicting non-sentinel node positivity in sentinel node-positive melanoma patientsK P Wevers, R Murali, E Bastiaannet, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 18, 2012
Prognostic value of the standardized uptake value for (18)F-fluorodeoxyglucose in patients with stage IIIB melanomaE Bastiaannet, O S Hoekstra, J R de Jong, et al.
The British Journal of Surgery|December 3, 2005
Impact of [18F]fluorodeoxyglucose positron emission tomography on surgical management of melanoma patientsE Bastiaannet, W J G Oyen, S Meijer, et al.
Pageof 8